4
Changes in Ownership
Context Therapeutics Inc. Filed Acc 0001628280-26-010616
Options or other derivatives
- Chief Executive Officer acquired 815,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Lehr Martin A. · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-19 | Grant or award : show line 1 in the form Stock Option (right to buy) | +815,000 | 815,000 | D |
Loading xslF345X05/wk-form4_1771881235.xml…